Optimizing diet and physical activity for taxi drivers
Official title: Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
Run by Memorial Sloan Kettering Cancer Center · NCT05770570 · Data updated 2026-11-12
This study is trying to help taxi drivers who are overweight or obese make healthier choices about their diet and exercise through personalized support and tools.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 1889 (estimated) |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | December 22, 2022 |
| Main results expected | February 26, 2027 |
| Study ends | August 11, 2027 |
| Registry record updated | September 2, 2026 |
| Trial ID | NCT05770570 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Hispanic/Latino adults aged 18 and older who are overweight or obese and seeking services at the Mexican Consulate.
✕Probably not a fit
Patients who do not identify as Hispanic/Latino or those who do not meet the BMI criteria for overweight or obesity may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to address the obesity crisis among taxi and for-hire vehicle drivers, a population that is predominantly low socioeconomic status and has high rates of overweight and obesity. Utilizing a hybrid effectiveness-implementation design, the study will incorporate counseling, text messages, phone calls, and self-monitoring tools to promote healthier lifestyle choices. Participants will be recruited from the Mexican Consulate's Ventanilla de Salud in New York City, focusing on those who self-identify as Mexican American or Hispanic/Latino and prefer to communicate in Spanish. The study seeks to improve health outcomes in a hard-to-reach population through tailored interventions.
Why it matters
Potential benefit: If successful, this study could lead to significant improvements in weight management and overall health for taxi and for-hire vehicle drivers.
How similar studies have gone: Other studies targeting similar populations with tailored interventions have shown promise, suggesting that this approach could be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For COMIDA participants only: * Self-Identifies as Mexican American or Mexican * Seeking services at the VDS of the Mexican Consulate * Prefers to speak in Spanish * All adults at least 18 years of age * Screens as obese (an adult who has a Body Mass Index (BMI) 30 or higher) or overweight (an adult who has a BMI between 25 - 29.9) * Agrees to be audio recorded For SANOS focus group participants only: * Self-identifies as Hispanic/Latino; * Seeking services at VDS or VDS Mobile; * Prefers to speak in Spanish; * At least 18 years of age; * Screens as obese (BMI ≥ 30 kg/m\^2) or overweight (BMI of 25 - 29.9 kg/m\^2); * Agrees to be audio recorded For SANOS RCT participants only: * Self-identifies as Hispanic/Latino; * Seeking services at VDS or VDS Mobile; * Prefers to speak in Spanish; * At least 18 years of age; * Screens as obese (BMI ≥ 30 kg/m\^2) or overweight (BMI of 25 - 29.9 kg/m\^2); * Owns a cell phone capable of receiving text messages; * Agrees to be audio recorded For Family COMIDA participants only: * Self-Identifies as Hispanic/Latino * Seeking services at the VDS (or has used VDS services in the past) of the Mexican - Consulate or VDS Mobile * Prefers to speak in Spanish * At least 18 years of age * Has at least one child under age 18 living in the same household * Owns a cell phone capable of receiving text messages * Willing to receive text messages (3 texts per week for 3 months) * Owns an internet connected device (eg, cell phone, tablet, etc) capable of conducting teleconference calls (eg, Zoom) For ROADmAP RCT participants only: * At least 21 years of age * Full-time (drives at least 35 hours per week) licensed taxi/FHV driver * Driver for at least 6 months * Seeking Health Fairs (or has used Health Fairs services in the past) * Speaks English, French, Bengali, or Spanish * Screens a as obese (BMI ≥ 30 kg/m2 \[≥25 kg/m2 for South Asians\]) or overweight (BMI of 25 - 29.9 kg/m2 s \[23- 24.9 kg/m2 for South Asians\]) * (BMI cut-offs are lower for South Asians, per WHO and American Diabetes Association recommendations) * Owns a cell phone capable of receiving text messages * Agrees to be audio-recorded For ROADmAP Phase 2 participants only: * At least 21 years of age * Driver who participated in ROADmAP RCT or manager at a taxi garage, Uber, Lyft or driver serving/union/organization * Agrees to be audio-recorded Exclusion Criteria: For COMIDA participants only: * Will not be in the NYC area for the study duration (3-4 months) Is pregnant or might be pregnant * Lactating women * Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study) * Has dietary restrictions (i.e. liquid diet) * Does not have a phone that accepts text messages or unwilling to accept text messages * Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional"s judgment * Has another family member already enrolled in COMIDA (as determined by patient report) For SANOS focus group participants only: * Is pregnant or might be pregnant; lactating women; * Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate); * Has dietary restrictions (i.e. liquid diet); * Has a household member who has already participated (or agreed to participate); For SANOS RCT participants only: * Is pregnant or might be pregnant; lactating women; for the study duration (6 months) * Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate); restricting diet; * Currently has dietary restrictions (i.e. liquid diet); * Has a household member who has already participated (or agreed to participate); * Has already participated in the study * Will not be in the NY Metropolitan area for the study duration (6 months) Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services) For Family COMIDA participants only: * Is pregnant or might be pregnant; lactating women for the study duration (3 months) * Will not be in the NY Metropolitan area for the study duration (3 months) Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study) * Has dietary restrictions (i.e. liquid diet) * Has another family member who has already participated in COMIDA or SANOS * Has already participated in the study * Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services) For ROADmAP RCT participants only: * Is pregnant or might be pregnant; lactating women; for the study duration (12 months) * Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate) that may restrict diet * Currently has dietary restrictions (i.e. liquid diet) * Has a household member who has already participated (or agreed to participate) * Has already participated in the study * Will not be in the NY Metropolitan area for 6 months from study enrollment * Is currently taking Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity Saxenda, Victoza, Phentermine (Adipex, Lomaira), Extended-release Phentermine/Topiramate (Qsymia), Extended-release Naltrexone/Bupropion (Contrave), Plenity, Orlistat (Xenical) or Other GLP-1 receptor agonist, or any other drug to treat obesity or there is less than 7 weeks since last dosage. * Has undergone weight loss/bariatric surgery or is planning to undergo such surgery in the next 12 months.
Where it's running
-
Mexican Consulate's Ventanilla de Salud (VDS)
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Jennifer Leng, MD, MPH — Memorial Sloan Kettering Cancer Center
- Study coordinator: Jennifer Leng, MD,MPH
- Email: lengj@mskcc.org
- Phone: 646-888-8057
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using tirzepatide to improve metabolic health in people with obesity or overweight
This study is testing if tirzepatide can help people with obesity or being overweight improve their metabolic health and lose weight over 22 weeks.
-
Berobenatide for knee pain in adults who are overweight or with obesity
This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.
-
Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists
This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
-
Monthly dose of PF-08653944 vs placebo in Chinese adults who are overweight or obese
This study tests whether berobenatide (PF-08653944) given once a month helps adults in China lose weight compared with a placebo.
-
FutureShape Family: a family-based weight-management program with semaglutide for children and parents
This trial tests whether a family-centered program that combines a prescription medication (semaglutide) with lifestyle support and app-based coaching can help adults with obesity and their children who are overweight/obese.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.